BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Net Current Assets History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹32 Cr | ₹33 Cr | ₹40 Cr | ₹41 Cr | ₹29 Cr |
What is the latest Net Current Assets ratio of BAFNA PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹32 Cr |
| Mar2025 | ₹33 Cr |
| Mar2024 | ₹40 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹29 Cr |
How is Net Current Assets of BAFNA PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹32 Cr | -1.26 | |
| Mar2025 | ₹33 Cr | -17.16 | |
| Mar2024 | ₹40 Cr | -2.81 | |
| Mar2023 | ₹41 Cr | 41.46 | |
| Mar2022 | ₹29 Cr | - | |
Compare Net Current Assets of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹843.6 Cr | 8.2% | 24.5% | 267.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,478.0 Cr | -0.8% | -2.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,031.0 Cr | 1.9% | 6.6% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,216.0 Cr | 0.3% | 2% | 35.9% | Stock Analytics | |
| CIPLA | ₹112,205.0 Cr | 0.9% | -0.8% | -10.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,040.0 Cr | 0.1% | 1.4% | -9.3% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 8.2% |
24.5% |
267.8% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses